MBX Biosciences Inc
MBX12.610USD
-1.140-8.29%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
421.48MMarket Cap
LossP/E TTM
MBX Biosciences Inc
12.610
-1.140-8.29%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
Total equity
Cash, cash equivalents and short-term investments
242.43%240.79M
--262.15M
--277.06M
--55.26M
--70.32M
- Cash and cash equivalents
-15.59%29.90M
--49.35M
--132.87M
--12.50M
--35.42M
-Short-term investments
504.41%210.88M
--212.80M
--144.20M
--42.76M
--34.89M
Receivables
595.98%1.39M
--682.00K
--858.00K
--164.00K
--199.00K
-Loans receivable
--1.39M
----
----
----
----
-Other receivables
----
--682.00K
--858.00K
--164.00K
--199.00K
Prepaid expenses
-26.56%1.48M
--3.65M
--2.41M
--3.13M
--2.01M
Other current assets
272.62%626.00K
--803.00K
--838.00K
--242.00K
--168.00K
Total current assets
236.02%244.28M
--267.29M
--281.17M
--58.80M
--72.70M
Non-current assets
Net Fixed Assets
81.82%1.60M
--1.20M
--1.18M
--1.28M
--880.00K
-Fixed Assets
89.78%2.10M
--1.62M
--1.54M
--1.57M
--1.11M
-Accumulated depreciation
120.80%499.00K
--422.00K
--364.00K
--289.00K
--226.00K
Other non-current assets
-97.13%50.00K
--50.00K
--50.00K
--2.80M
--1.74M
Total non-current assets
-37.09%1.65M
--1.25M
--1.23M
--4.08M
--2.62M
Total assets
226.51%245.93M
--268.54M
--282.40M
--62.88M
--75.32M
Liabilities
Current liabilities
-Other payables
--0.00
----
----
----
----
Accrued expenses
160.61%6.11M
--5.54M
--5.75M
--4.81M
--2.34M
Other current liabilities
--0.00
----
----
----
----
Total current liabilities
84.01%10.48M
--11.05M
--10.92M
--8.20M
--5.70M
Non-current liabilities
Long-term debt and lease liabilities
-100.00%0.00
--0.00
--44.00K
--87.00K
--129.00K
-Long-term lease liabilities
----
--0.00
--44.00K
--87.00K
--129.00K
Other non-current liabilities
-87.57%23.00K
--42.00K
--68.00K
--125.00K
--185.00K
Total non-current liabilities
-92.68%23.00K
--42.00K
--112.00K
--212.00K
--314.00K
Total liabilities
74.78%10.50M
--11.09M
--11.03M
--8.41M
--6.01M
Shareholders' equity
Common equity
8036.87%396.75M
--394.89M
--393.18M
--5.91M
--4.88M
Preferred equity
----
----
----
--152.36M
--152.36M
Retained earnings
-83.56%-161.38M
---137.50M
---121.92M
---103.78M
---87.92M
Capital reserves
8038.44%396.75M
--394.89M
--393.18M
--5.91M
--4.88M
Gains losses not affecting retained earnings
1866.67%53.00K
--55.00K
--106.00K
---15.00K
---3.00K
Total equity
239.67%235.42M
--257.44M
--271.37M
--54.47M
--69.31M
Currency unit
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
